U.S. Beverage Stock News

Why Madrigal Pharmaceuticals Is On Investors’ Radar Madrigal Pharmaceuticals (MDGL) has attracted fresh attention after recent market moves, with the share price near US$431.53 and returns showing mixed results over the past year and past 3 months. For investors tracking performance, the stock shows a 1 day return of about a 0.3% decline and a 7 day return of roughly a 0.8% decline, while the past month and past 3 months reflect deeper pullbacks. See our latest analysis for Madrigal...

If you are wondering whether Chubb's current share price reflects its true worth, you are not alone. Many investors are asking if the recent price level still offers value. Chubb shares last closed at US$322.76, with returns of 4.1% year to date and 15.2% over the past year, while the stock shows a 3.4% decline over 7 days and a 1.0% decline over 30 days that may have caught your eye. Recent headlines around Chubb have focused on its position in the insurance space and how investors are...

Wondering if Exelon at around US$48.84 is giving you fair value right now, or if the market is missing something important about this utility giant. The stock has been relatively steady over the past week with a 0.8% decline, while its 30 day return of 11.1% and 1 year return of 18.7% may catch the eye of investors who are thinking about growth potential or shifting risk perceptions. Those moves sit against a wider backdrop of ongoing interest in regulated utilities. In this area, investors...

In early March 2026, Hewlett Packard Enterprise reported past first-quarter results showing higher sales of US$8,425 million, raised its full-year 2026 earnings guidance, continued an extensive multi-year share buyback now totaling about US$12.86 billion, and affirmed a regular dividend of US$0.1425 per share. A key insight is that networking has become a central earnings engine, helping drive record per-share profits and stronger guidance, while the company simultaneously returns large...

If you are wondering whether Ralph Lauren's share price still offers value after a strong run, this article will walk through what the current market price might be implying about the business. The stock last closed at US$338.95. While the share price shows a 5.8% decline over 7 days and a 2.6% decline over 30 days, it also shows a 6.5% decline year to date, a 52.4% gain over 1 year, and more than 3x over 3 years. Recent coverage around Ralph Lauren has focused on its brand strength, product...

Perimeter Solutions, Inc. reported past fourth-quarter 2025 sales of US$102.75 million, up from US$86.23 million a year earlier, but swung to a net loss of US$140.23 million and a basic loss per share of US$0.94 from prior-year earnings. For 2025 as a whole, the company increased sales to US$652.86 million while recording a much larger net loss of US$206.37 million, against the backdrop of its role as the sole aerial fire-retardant supplier under a new five-year U.S. Department of...

Gallagher (NYSE:AJG) released its 2026 Employee Communications Report highlighting a widespread lack of structured change management communication strategies. The report finds internal communications teams are increasingly overwhelmed, raising risks around leadership trust and employee burnout. The findings point to an emerging organizational risk that has attracted limited attention compared with topics like deals or quarterly earnings. For investors looking at Gallagher (NYSE:AJG), this...

America First Refining has broken ground on what is described as the first major US refinery project in nearly 50 years. The project highlights renewed attention on domestic refining capacity and long term US energy independence goals. Marathon Petroleum (NYSE:MPC), the largest US refiner by capacity, sits at the center of these shifts given its scale and link to American shale oil. For you as an investor, this new refinery project puts a fresh spotlight on the core business of Marathon...

Pratt & Whitney, an RTX (NYSE:RTX) business, received a follow on contract to supply TJ150 turbojet engines for Leidos Dynetics' AGM-190A small cruise missile program. The contract expands RTX's role in next generation autonomous weapon systems and highlights the use of additive manufacturing in engine development. For you as an RTX watcher, this contract sits in the core of the company’s defense profile, where Pratt & Whitney focuses on propulsion for military platforms. Interest in...

Why ERAS-0015 is at the center of the story Erasca (ERAS) has just exercised its option to secure worldwide rights to its pan RAS molecular glue ERAS-0015 by expanding its license with Joyo Pharmatech to cover China, Hong Kong, and Macau. This follows a recent clinical trial collaboration with Tango Therapeutics involving ERAS-0015 and increased analyst attention tied to upcoming Phase 1 data, which helps explain why the stock is attracting more investor focus. See our latest analysis for...

FTAI Aviation (FTAI) is back on traders’ radar after a Q4 2025 earnings miss was followed by a 6.14% share price jump, upbeat 2026 guidance, and fresh leadership appointments in key finance roles. See our latest analysis for FTAI Aviation. That Q4 earnings miss and the leadership reshuffle come after a strong run, with a 90 day share price return of 42.71% and a very large 3 year total shareholder return. The recent 7 day pullback of 8.13% looks more like a pause than a change in...

C3.ai (AI) is back in focus after quarterly results showing a 46% year on year revenue drop, weaker guidance for the year ahead, and a restructuring plan featuring layoffs and cost cuts. See our latest analysis for C3.ai. Those weak quarterly numbers and the restructuring plan help explain why C3.ai’s 30 day share price return is 20.45% lower and its 1 year total shareholder return is 57.17% lower. This signals fading momentum despite new product launches and an upcoming conference...

FactSet Research Systems overview after recent price moves FactSet Research Systems (FDS) has drawn attention after a recent pullback, with the stock down about 3% over the past day and 8.8% over the past week, while its past month return is slightly positive. Over the past 3 months, the share price shows a 29.5% decline and the 1 year total return is down about 51.5%. This has prompted some investors to reassess how current pricing lines up with FactSet’s fundamentals and value score. See...

In recent weeks, United States Antimony Corporation has secured a US$27 million Department of War award for domestic critical mineral extraction and processing, while management has promoted this and an initial resource report on the Fostung Tungsten property on major business media and at multiple Toronto conferences. These developments underscore how government-backed funding and an estimated US$4.60 billions gross revenue opportunity at Fostung could reshape the company’s role in North...

Jefferies has initiated coverage on Life Time Group Holdings (LTH), highlighting the company’s position as a premium fitness brand. This new Wall Street attention is putting the stock on more investor watchlists. See our latest analysis for Life Time Group Holdings. Life Time Group Holdings’ share price has pulled back over the past month, with a 30 day share price return of a 10.18% decline. However, the 3 year total shareholder return of 62.84% points to a much stronger longer term picture,...

If you are wondering whether Alliant Energy's current share price still offers value or if most of the opportunity is already priced in, this article walks through the key pieces you need to consider. The stock last closed at US$70.81, with returns of 5.8% over 30 days, 8.0% year to date, 17.5% over 1 year, 47.7% over 3 years, and 61.0% over 5 years. This performance may have shifted how investors think about its risk and return profile. Recent coverage of Alliant Energy has focused on its...

Geron (GERN) has put fresh equity financing in focus after announcing a US$150 million at the market follow on common stock offering, alongside a new universal shelf registration covering multiple security types. See our latest analysis for Geron. At a share price of US$1.66, Geron has seen a 19.42% 90 day share price return and a 25.76% year to date share price return. However, its 1 year total shareholder return of a 6.21% decline points to building short term momentum against a weaker...

If you are wondering whether Vail Resorts is attractively priced after a long slide in the share price, this article walks through what the current valuation might be telling you. The stock last closed at US$138.53, with returns of 1.6% over 7 days, a 1.8% decline over 30 days, a 3.4% gain year to date, and declines of 9.2%, 26.2% and 47.5% over the past 1, 3 and 5 years respectively. Recent news coverage has focused on Vail Resorts as a large operator in the ski and mountain resort space,...

Stock performance snapshot and recent context Qiagen (QGEN) has seen its share price under pressure recently, with a 4.2% one day decline and negative returns over the past week, month, and past 3 months. This may prompt investors to reassess the setup. See our latest analysis for Qiagen. That 4.2% one day share price decline fits into a weaker recent pattern, with a 30 day share price return of 18.85% and a year to date share price return of a 13.37% decline, even though the 1 year total...

Recent performance snapshot Coinbase Global (COIN) has seen mixed share performance recently, with a 1 day gain of 1.1% and a 3.9% decline over the past week, alongside a reported last close of US$198.63. Over the past month the stock shows a 22.2% return, while the past 3 months reflect a 25.7% decline and the year to date return stands at a 16.0% decline. See our latest analysis for Coinbase Global. At the current share price of US$198.63, Coinbase Global’s recent 22.2% 1 month share price...

Recent performance context for Synopsys (SNPS) Without a specific news catalyst, Synopsys (SNPS) has still been on many investors' radars, given its recent share performance and its role supplying design and IP tools to the semiconductor and electronics industries. See our latest analysis for Synopsys. At a share price of US$432.98, Synopsys has seen its 90 day share price return of 9.28% and year to date share price return of 9.87% contrast with a 5 year total shareholder return of 83.77%...

Wondering whether CarGurus at around US$31.39 is still offering value, or if most of the opportunity has already been priced in? This article is built to help you answer that question. The stock has been choppy recently, with a 6.4% decline over the last week, a 10.1% gain over the last 30 days, and returns of 0.7% over 1 year, 80.4% over 3 years, and 20.7% over 5 years. These swings come as investors continue to reassess online auto platforms more broadly and react to ongoing sentiment...

If you are wondering whether Clorox is fairly priced or offering value at today's levels, its recent share performance gives you a useful starting point. The stock last closed at US$112.15, with a 7 day return of a 4.5% decline, a 30 day return of a 6.2% decline, and a year to date gain of 11.2%, against a 1 year return of a 20.8% decline and a 5 year return of a 30.3% decline. Recent coverage around Clorox has focused on its role as a well known consumer staples name and how it fits into...

ASP Isotopes (ASPI) is drawing fresh attention after subsidiary Quantum Leap Energy signed a non binding MOU with a major U.S. nuclear operator to explore support for U.S. based advanced fuel cycle facilities. See our latest analysis for ASP Isotopes. The MOU headlines arrive after a mixed year for ASP Isotopes, with the latest share price at $5.68, a 7 day share price return of 11.15% and a 1 year total shareholder return of 44.9%. This suggests that recent optimism is building on already...